Evidence map›Paper›PMID 42179840›Full record

ReviewFrontiers in chemistry2026

Linking molecular architecture to antibacterial functions: a chemical biology view of cyclic depsipeptides.

Sachin Baravkar, Varsha J Thombare, Yuezhou Wu, Nitin A Patil

Abstract readReview
In one paragraph

Review in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sachin Baravkar *Center for Drug Discovery, RTI International, Research Triangle Park, Durham, NC, United States.
Varsha J Thombare *Center for Drug Discovery, RTI International, Research Triangle Park, Durham, NC, United States.
Yuezhou WuCenter for Drug Discovery, RTI International, Research Triangle Park, Durham, NC, United States.
Nitin A PatilCenter for Drug Discovery, RTI International, Research Triangle Park, Durham, NC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial depsipeptides and cyclodepsipeptides represent a structurally diverse class of natural products that have gained renewed attention as both antibacterial agents and molecular tools to interrogate bacterial physiology. Characterized by the incorporation of ester linkages within macrocyclic peptide frameworks, these molecules exhibit unique conformational properties that underpin distinct modes of action including lipid II recognition, membrane perturbation, and enzyme modulation. This review summarizes advances in discovery, chemical synthesis, and structure activity relationship studies across major depsipeptide families, highlighting how precise chemical features such as macrocycle topology, stereochemical configuration, hydroxylation patterns, and lipidation dictate biological function. By integrating mechanistic insights from chemical biology, microbiology, and medicinal chemistry, we illustrate how cyclodepsipeptides serve as privileged scaffolds for probing bacterial cell envelope organization and essential biosynthetic pathways. In the context of escalating antimicrobial resistance and limited innovation in small molecule antibiotics, these macrocyclic peptides offer valuable opportunities for mechanism driven probe development and therapeutic translation. Collectively, this article provides a unified framework linking molecular structure to antibacterial activity and aims to guide the rational design of next-generation peptide-based antibiotics.

Indexed as

antimicrobial drugscyclic peptidedepsipeptidespeptide synthesisstructure-activity relationship (SAR)

Identifiers

PMID42179840
PMCPMC13194151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.